Sommer MO - Search Results

1

Relation between tetR and tetA expression in tetracycline resistant Escherichia coli.

Møller TS, Overgaard M, Nielsen SS, Bortolaia V, Sommer MO, Guardabassi L, Olsen JE. Møller TS, et al. Among authors: sommer mo. BMC Microbiol. 2016 Mar 12;16:39. doi: 10.1186/s12866-016-0649-z. BMC Microbiol. 2016. PMID: 26969122 Free PMC article.

2

Antibiotics and the resistant microbiome.

Sommer MO, Dantas G. Sommer MO, et al. Curr Opin Microbiol. 2011 Oct;14(5):556-63. doi: 10.1016/j.mib.2011.07.005. Epub 2011 Jul 27. Curr Opin Microbiol. 2011. PMID: 21802347 Review.

3

Human intestinal cells modulate conjugational transfer of multidrug resistance plasmids between clinical Escherichia coli isolates.

Machado AM, Sommer MO. Machado AM, et al. Among authors: sommer mo. PLoS One. 2014 Jun 23;9(6):e100739. doi: 10.1371/journal.pone.0100739. eCollection 2014. PLoS One. 2014. PMID: 24955767 Free PMC article.

4

Evolution of Escherichia coli to 42 °C and subsequent genetic engineering reveals adaptive mechanisms and novel mutations.

Sandberg TE, Pedersen M, LaCroix RA, Ebrahim A, Bonde M, Herrgard MJ, Palsson BO, Sommer M, Feist AM. Sandberg TE, et al. Mol Biol Evol. 2014 Oct;31(10):2647-62. doi: 10.1093/molbev/msu209. Epub 2014 Jul 10. Mol Biol Evol. 2014. PMID: 25015645 Free PMC article.

5

CTX-M-1 β-lactamase expression in Escherichia coli is dependent on cefotaxime concentration, growth phase and gene location.

Kjeldsen TS, Overgaard M, Nielsen SS, Bortolaia V, Jelsbak L, Sommer M, Guardabassi L, Olsen JE. Kjeldsen TS, et al. J Antimicrob Chemother. 2015 Jan;70(1):62-70. doi: 10.1093/jac/dku332. Epub 2014 Sep 1. J Antimicrob Chemother. 2015. PMID: 25182062

6

Extended spectrum β-lactamase-producing Escherichia coli forms filaments as an initial response to cefotaxime treatment.

Kjeldsen TS, Sommer MO, Olsen JE. Kjeldsen TS, et al. Among authors: sommer mo. BMC Microbiol. 2015 Mar 8;15:63. doi: 10.1186/s12866-015-0399-3. BMC Microbiol. 2015. PMID: 25888392 Free PMC article.

7

Adaptive responses to cefotaxime treatment in ESBL-producing Escherichia coli and the possible use of significantly regulated pathways as novel secondary targets.

Møller TS, Rau MH, Bonde CS, Sommer MO, Guardabassi L, Olsen JE. Møller TS, et al. Among authors: sommer mo. J Antimicrob Chemother. 2016 Sep;71(9):2449-59. doi: 10.1093/jac/dkw198. Epub 2016 Jun 5. J Antimicrob Chemother. 2016. PMID: 27272725

8

Genome Dynamics of Escherichia coli during Antibiotic Treatment: Transfer, Loss, and Persistence of Genetic Elements In situ of the Infant Gut.

Porse A, Gumpert H, Kubicek-Sutherland JZ, Karami N, Adlerberth I, Wold AE, Andersson DI, Sommer MOA. Porse A, et al. Front Cell Infect Microbiol. 2017 Apr 12;7:126. doi: 10.3389/fcimb.2017.00126. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28447026 Free PMC article.

9

Prediction of antibiotic resistance: time for a new preclinical paradigm?

Sommer MOA, Munck C, Toft-Kehler RV, Andersson DI. Sommer MOA, et al. Nat Rev Microbiol. 2017 Nov;15(11):689-696. doi: 10.1038/nrmicro.2017.75. Epub 2017 Jul 31. Nat Rev Microbiol. 2017. PMID: 28757648 Review.

10

Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli.

Møller TSB, Liu G, Hartman HB, Rau MH, Mortensen S, Thamsborg K, Johansen AE, Sommer MOA, Guardabassi L, Poolman MG, Olsen JE. Møller TSB, et al. Sci Rep. 2020 May 21;10(1):8438. doi: 10.1038/s41598-020-64995-1. Sci Rep. 2020. PMID: 32439837 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters